Almirincomb 4 mg/5 mg tablete
Name | Almirincomb 4 mg/5 mg tablete |
---|---|
Marketing Authorisation Number | HR-H-203071244 |
Active Substance | perindopril-tert-butilamin amlodipinbesilat |
Composition | jedna tableta sadrži 4 mg perindopril-tert-butilamina što odgovara 3,34 mg perindoprila i 5 mg amlodipina (u obliku besilata) |
Pharmaceutical Form | tableta |
Manufacturer | Adamed Pharma S.A., Pabianice, Poljska
Jadran Galenski laboratorij d.d., Rijeka, Hrvatska |
Marketing Authorisation Holder | Jadran Galenski laboratorij d.d., Svilno 20, Rijeka, Hrvatska |
Marketing Authorisation Date | 27.11.2019 |
MA Period of Validity | 27.11.2024 |
Classification Number | UP/I-530-09/18-01/94 |
Registration Number | 381-12-01/70-19-15 |
Prescription | na recept |
Type of prescription | ponovljivi recept |
Distribution | u ljekarni |
Advertising to general public | zabranjeno |
ATC Code | C09BB04 |
Medicinal product marketed in the Croatia | Da |
SmPC | download |
PL | download |
Public Assessment Report | download |